Case report: Dupilumab therapy for alopecia areata in a 4-year-old patient resistant to baricitinib

Alopecia areata (AA) is a non-scarring hair loss disorder. Alopecia totalis (AT) and alopecia universalis (AU) are the severe subtypes of AA. Age of onset before 6 years of age, disease duration of more than 1 year, and extensive alopecia involving more than 50% of the scalp (including AT or AU) sug...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Lu Cai, Yi Wei, Min Zhao, Jia Zhuo, Xiao Tao, Mao Lin
Format:	Artigo
Jezik:	Inglês
Izdano:	Frontiers Media S.A. 2023-10-01
Serija:	Frontiers in Medicine
Teme:	alopecia areata dupilumab resistant to baricitinib pediatric patients Th1 Th2
Online dostop:	https://www.frontiersin.org/articles/10.3389/fmed.2023.1253795/full
Oznake:	Označite Brez oznak, prvi označite!